ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI)

Historical Holders from Q1 2014 to Q4 2025

Type / Class: Equity / Common Stock, $2 par value per share
Symbol: OMI on NYSE
Shares outstanding: 77,519,568
Price per share: $2.80
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 72,618,801
Total reported value: $348,695,265
% of total 13F portfolios: 0%
Share change: -2,485,343
Value change: -$36,945,473
Avg buy value change: +0%
Avg sell value change: -0%
Number of holders: 196
Price from insider filings: $5.40

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Coliseum Capital Management, LLC	17%	+12%	$62,883,874	+$7,381,690	13,100,807	+13%	Coliseum Capital Management, LLC	12 Nov 2025
VANGUARD GROUP INC	7.7%		$28,621,666		5,962,847		The Vanguard Group	30 Sep 2025
BlackRock, Inc.	7.1%	-51%	$29,888,199	-$32,238,791	5,454,051	-52%	BlackRock, Inc.	30 Sep 2025
DIMENSIONAL FUND ADVISORS LP	4.5%		$16,836,283		3,507,559		Dimensional Fund Advisors LP	30 Sep 2025
FMR LLC	3.5%	-50%	$19,031,279	-$21,607,348	2,718,754	-53%	FMR LLC	31 Mar 2025

As of 30 Sep 2025, ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI) has 196 institutional shareholders filing 13F forms. They hold 72,618,801 shares. of 77,519,568 outstanding shares (94%) .

Top 25 institutional shareholders own 77% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
Coliseum Capital Management, LLC	17%	13,100,807	+13%	6.1%	$62,883,874
VANGUARD GROUP INC	7.7%	5,962,847	-26%	0%	$28,621,666
BlackRock, Inc.	7.2%	5,613,838	-48%	0%	$26,946,422
DIMENSIONAL FUND ADVISORS LP	4.5%	3,507,559	-18%	0%	$16,835,489
MILLENNIUM MANAGEMENT LLC	4.2%	3,261,254	+192%	0.01%	$15,654,019
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	4.1%	3,208,915	+4.3%	0%	$15,402,792
Invenomic Capital Management LP	3.5%	2,749,122		0.69%	$13,195,786
PARADIGM CAPITAL MANAGEMENT INC/NY	3.4%	2,611,600	+32%	0.54%	$12,535,680
D. E. Shaw & Co., Inc.	3%	2,319,984	+62%	0.01%	$11,135,923
STATE STREET CORP	2.5%	1,964,536	-36%	0%	$9,429,773
CITADEL ADVISORS LLC	2.4%	1,893,777	+523%	0.01%	$9,090,129
MORGAN STANLEY	2.1%	1,601,058	+43%	0%	$7,685,084
GEODE CAPITAL MANAGEMENT, LLC	1.9%	1,460,801	-18%	0%	$7,013,071
JANE STREET GROUP, LLC	1.7%	1,332,397		0.01%	$6,395,506
Dana Investment Advisors, Inc.	1.6%	1,265,560	+24%	0.18%	$6,074,688
TOWLE & CO	1.6%	1,247,959	+73%	1.5%	$5,990,203
TWO SIGMA INVESTMENTS, LP	1.4%	1,059,371	+51%	0.01%	$5,084,981
Connor, Clark & Lunn Investment Management Ltd.	1.2%	926,979	-7.4%	0.01%	$4,449,499
NORTHERN TRUST CORP	0.93%	718,698	-22%	0%	$3,449,751
Empowered Funds, LLC	0.92%	716,184	+91%	0.03%	$3,437,683
HRT FINANCIAL LP	0.92%	711,684	+634%	0.01%	$3,416,000
GOLDMAN SACHS GROUP INC	0.9%	696,791	+94%	0%	$3,344,596
RENAISSANCE TECHNOLOGIES LLC	0.89%	690,800	-19%	0%	$3,315,840
BANK OF AMERICA CORP /DE/	0.77%	598,663	+169%	0%	$2,873,583
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.77%	598,358	-0.13%	0.06%	$2,872,118

Institutional Holders of ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	88,601	$238,466	+$42,521			280%	5
2025 Q3	72,618,801	$348,695,265	-$36,945,473	$2,005,836	$1,898,316	480%	196
2025 Q2	74,911,798	$681,593,001	+$6,794,289	$1,533,793	$1,366,192	910%	232
2025 Q1	74,234,901	$669,904,713	-$41,362,354	$685,377	$1,061,025	903%	242
2024 Q4	75,999,825	$993,410,302	-$18,686,473	$120,244	$1,550,102	1,307%	196
2024 Q3	76,365,231	$1,197,927,357	+$1,856,856	$1,445,049	$2,493,039	1,569%	213
2024 Q2	77,398,830	$1,045,066,388	-$17,380,767	$576,450	$3,063,150	1,350%	221
2024 Q1	77,199,314	$2,139,054,036	+$26,197,352	$5,417,732	$21,982,770	2,771%	224
2023 Q4	206,701	$3,983,128	+$1,440,278			1,927%	3
2023 Q3	79,858,116	$1,290,561,342	+$95,776,425	$1,869,712	$4,676,704	1,616%	205
2023 Q2	74,529,900	$1,419,135,822	+$9,529,628	$1,555,568	$6,789,664	1,904%	223
2023 Q1	74,092,292	$1,077,976,440	-$30,734,101	$2,783,415	$2,437,125	1,455%	212
2022 Q4	75,383,588	$1,472,282,410	-$32,149,920	$1,578,024	$2,728,318	1,953%	209
2022 Q3	75,453,751	$1,818,625,678	-$61,404,133	$4,622,000	$4,687,000	2,409.99%	207
2022 Q2	78,503,403	$2,463,048,099	+$39,445,731	$2,927,224	$8,958,096	3,145%	239
2022 Q1	77,035,957	$3,391,591,368	+$216,131,408	$10,012,000	$9,757,000	4,402%	255
2021 Q4	72,003,396	$3,132,242,501	-$84,643,395	$73,615,000	$13,703,000	4,349.98%	262
2021 Q3	71,398,337	$2,234,602,466	+$61,408,724	$22,595,000	$11,688,566	3,128.99%	241
2021 Q2	68,073,762	$2,880,861,652	+$140,775,935	$20,993,000	$18,971,000	4,233%	255
2021 Q1	65,614,369	$2,466,057,454	-$3,321,762	$23,076,000	$18,648,000	3,759%	251
2020 Q4	63,767,387	$1,724,988,583	+$289,029,355	$9,883,000	$18,720,550	2,705%	223
2020 Q3	54,478,221	$1,363,467,183	-$12,475,330	$12,034,000	$32,557,000	2,510.96%	198
2020 Q2	56,144,429	$427,735,951	+$3,966,896	$907,000	$3,060,000	761.97%	178
2020 Q1	54,982,885	$502,996,182	-$1,714,056	$830,000	$5,615,000	914.98%	168
2019 Q4	56,887,308	$294,142,891	+$4,985,624	$1,624,000	$3,494,000	516.99%	168
2019 Q3	55,189,243	$320,629,234	+$10,242,133	$4,322,000	$1,670,000	580.98%	161
2019 Q2	51,405,024	$164,321,638	-$4,003,276	$407,000	$83,000	319.98%	148
2019 Q1	46,093,405	$188,963,720	-$19,482,453	$1,142,000	$299,000	410%	166
2018 Q4	58,472,510	$370,278,264	+$5,417,859	$803,000	$368,000	632.98%	193
2018 Q3	55,676,772	$919,692,202	-$4,834,554	$6,282,000	$3,194,000	1,652%	206
2018 Q2	56,474,648	$943,754,147	-$371,499	$6,581,000	$4,176,000	1,671%	223
2018 Q1	55,967,944	$871,131,956	-$52,821,168	$8,309,000	$2,125,000	1,554.99%	234
2017 Q4	59,728,438	$1,127,827,881	-$64,448,450	$5,527,000	$1,888,000	1,887.99%	224
2017 Q3	60,415,740	$1,764,541,165	-$14,562,620	$1,016,000	$333,000	2,920.01%	254
2017 Q2	60,284,613	$1,940,490,185	-$13,134,451	$327,000	$313,000	3,218.98%	268
2017 Q1	61,034,097	$2,111,738,210	+$334,882,776	$607,000	$453,000	3,459.97%	276
2016 Q4	58,378,466	$2,060,316,952	-$3,558,429	$822,000	$498,000	3,529%	277
2016 Q3	58,602,074	$2,032,518,625	-$109,250,439	$1,698,000	$1,004,000	3,473%	280
2016 Q2	61,439,045	$2,296,427,944	-$64,344,175	$677,000	$2,778,000	3,738%	276
2016 Q1	60,560,521	$2,447,715,349	-$5,564,990	$348,000	$3,137,000	4,041.97%	281
2015 Q4	62,490,192	$2,248,637,214	-$68,584,661	$630,000	$12,309,000	3,598%	262
2015 Q3	65,318,059	$2,086,336,977	+$75,228,540		$1,278,000	3,193.99%	244
2015 Q2	61,046,558	$2,075,687,595	+$52,282,123		$6,480,000	3,399.97%	234
2015 Q1	61,095,105	$2,067,770,810	+$80,005,922	$0	$0	3,383.99%	229
2014 Q4	58,668,292	$2,059,982,972	-$61,570,958	$130,000	$126,000	3,510.96%	224
2014 Q3	60,478,214	$1,980,104,575	-$39,186,136	$7,000	$29,000	3,274.01%	217
2014 Q2	61,498,409	$2,089,731,972	-$14,549,323	$200,000	$37,000	3,397.92%	236
2014 Q1	60,780,139	$2,129,071,381	-$25,977,829		$4,000	3,502.99%	237